Nexilico is an early-stage startup developing predictive computational platforms for gut microbiome precision medicine.
Nexilico has raised $275K in total funding. The most recent round was Grant. The last funding was announced in September 2023.
Nexilico's investors include National Science Foundation, SkyDeck Berkeley, National Institutes of Health, CITRIS Foundry.
Nexilico is headquartered in Berkeley, United States.
Nexilico is an early-stage startup developing predictive computational platforms for gut microbiome precision medicine.
Nexilico is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nexilico — Funding & Investors." VCBacked, September 1, 2023, https://www.vcbacked.co/company/nexilico. Accessed July 20, 2026.
VCBacked. (2023). Nexilico — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/nexilico
{{cite web |title=Nexilico — Funding & Investors |url=https://www.vcbacked.co/company/nexilico |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated